Trial Profile
Randomized Trial to Test Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women (RAMBLE)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Nov 2023
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban
- Indications Venous thromboembolism
- Focus Adverse reactions
- Acronyms RAMBLE
- 18 Apr 2023 Status changed from recruiting to completed.
- 18 Apr 2023 Status changed from recruiting to completed.
- 04 Dec 2019 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.